 Webcast and Conference Call to be Held at 5 p.m. EDT on August 4, 2020SAN DIEGO, July 28, 2020 GLOBE NEWSWIRE -- Otonomy, Inc. Nasdaq: OTIC, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results for the second quarter of 2020 and provide a corporate update at 5 p.m. EDT on August 4, 2020.The live call may be accessed by dialing 877 305-6769 for domestic callers and 678 562-4239 for international callers with conference ID code number: 3489668. A live webcast of the call will be available online in the investor relations section of Otonomys website at and will be archived there for 30 days.About Otonomy Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménières disease, hearing loss, and tinnitus. For additional information please visit Inquiries: Spectrum Science Chloé-Anne Ramsey Vice President 404.865.3601 Inquiries: Westwicke ICR Robert H. Uhl Managing Director 858.356.5932 